A few studies have demonstrated an up-regulation of FAK expression during the transformational process in which normal tissue is invaded by cancer after the stage of in situ carcinoma, suggesting that up-regulation of FAK might be an early event in carcinogenesis [15–17]. The gene discussed is PTK2; the disease is cancer.